Harvard University professor of philosophy Michael Sandel has been described as a “philosopher with the global profile of a rock star,” known across the globe for his lively Socratic debates that aim to restore the lost art of respectful discussion. Sandel is the bestselling author of books on justice, ethics, democracy, and markets that have been translated into over 30 languages. Sandel has been a visiting professor at the Sorbonne, delivered the Tanner Lectures on Human Values at Oxford, served on the U.S. President’s Council on Bioethics, and is a member of the American Academy of Arts and Sciences. A graduate of Brandeis University, he received his doctorate from Oxford University, where he was a Rhodes Scholar.

Sandel’s books—on justice, democracy, ethics, technology, and markets—have been translated into more than 30 languages. They include Justice: What’s the Right Thing to Do?; What Money Can’t Buy, and The Tyranny of Merit: Can We Find the Common Good?, which seeks a way beyond our polarized politics. A new edition of his classic book Democracy’s Discontent has been described as “essential--and ultimately hopeful--reading for all those who wonder if our democratic experiment will survive in the twenty-first century.”

Sandel’s legendary course “Justice,” one of the most popular in Harvard’s history, is freely available online and has been viewed by tens of millions. His BBC series The Global Philosopher engages participants from around the world in discussing the ethical issues lying behind the headlines. In this and other television, radio, and online programs, Sandel explores tech ethics, robots and AI, markets and morals, climate change, free speech, and other topical issues.

Sandel’s renowned interactive public lectures on the big civic questions of the day show how reasoned debate, leavened with humor and mutual respect, can produce dialogue across our differences.

A “master of life’s big questions” (Guardian), Sandel’s live events have packed St. Paul’s Cathedral (London), the Sydney Opera House (Australia), the Delacorte Theater in New York’s Central Park, and an outdoor stadium in Seoul (S. Korea), where 14,000 came to hear him speak. 

A Visionary Leader in Healthcare Innovation and Healthcare Policy

Dr. Francis Collins is one of the most influential scientists and healthcare policy leaders of our time, recognized for his groundbreaking contributions to genomics, precision medicine, and national healthcare initiatives. As the Director of the National Institutes of Health (NIH) from 2009 to 2021, he played a pivotal role in shaping the nation’s biomedical research agenda under three U.S. Presidents—Barack Obama, Donald Trump, and Joe Biden. His leadership was instrumental in advancing critical research on diabetes, Alzheimer’s disease, cancer, neuroscience, and the COVID-19 pandemic.

Revolutionizing Medicine: The Human Genome Project and Beyond

Before his tenure at NIH, Dr. Collins led one of the most significant scientific efforts in modern history—the Human Genome Project. Completed in 2003, this international collaboration successfully mapped the entire human genetic code, revolutionizing genetic medicine, diagnostics, and targeted therapies. His leadership in genomics has had a lasting impact on precision medicine, transforming the way diseases are prevented, diagnosed, and treated.

Physician and geneticist Dr. Francis Collins' life story is one of curiosity, discovery, and deep human connection. His journey from a small-town upbringing to leading the Human Genome Project and serving as Director of the National Institutes of Health is a testament to the power of perseverance, intellectual courage, and ethical leadership.

Guiding National Healthcare Policy and Research

As NIH Director, Collins secured bipartisan support for major healthcare initiatives, fostering public-private partnerships to accelerate biomedical innovation. Under his leadership:

• The Cancer Moonshot Initiative was launched to advance cancer research and treatment.

• The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative pushed the frontiers of neuroscience.

• The All of Us Research Program paved the way for precision medicine by collecting diverse genetic and health data to drive personalized treatment strategies.

• NIH-led COVID-19 vaccine and treatment research played a crucial role in the rapid development of mRNA vaccines and therapeutics.

A Lifelong Commitment to Science and Innovation

Following his tenure as Acting Science Advisor and Special Projects Advisor to President Biden (2022-2023), Collins returned to his NIH research laboratory to continue investigating genetic factors in diabetes and premature aging. His research remains at the forefront of translating genetic discoveries into real-world medical applications.

Craig Venter, Ph.D. is regarded as one of the leading scientists of the 21st century for his numerous, invaluable contributions to genomic research. He decoded the genome of the first free-living organism, a bacterium, as well as fruit fly, mouse, rat, and human genomes, published in Science. Dr. Venter is Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit dedicated to genomic research and the exploration of social and ethical issues in genomics. He is also a co-founder of Viridos, Inc. and Human Longevity, Inc. Dr. Venter currently serves on the Scientific Advisory Board at Bluestar Genomics, a company leading the development of non-invasive early cancer detection. With a keen focus on the intersection of technology and biology, Venter's talks provide a glimpse into the future of healthcare and the possibilities of genetic-driven solutions.

Dr. Venter is also the recipient of numerous honorary degrees, public honors, and scientific awards, including the United States National Medal of Science, the Gairdner Foundation International Award, the Paul Ehrlich and Ludwig Darmstaedter Prize, and the King Faisal International Award for Science. Dr. Venter is a member of numerous prestigious scientific organizations including the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Society for Microbiology. His insights have been sought by hosts including Princeton University, PepsiCo, the American Academy of Anti-Aging Medicine, and more.

American icon Dr. Mae C. Jemison broke more than the sound barrier in 1992 when she climbed aboard the space shuttle Endeavour – she became the first woman of color to travel into space. Dr. Jemison was NASA’s first Science Mission Specialist, performing experiments in material science, life science, and human adaptation to weightlessness. She now leads 100 Year Starship (100YSS), a bold, far reaching nonprofit initiative to assure the capabilities exist for human travel beyond our solar system to another star within the next 100 years. Dr. Jemison is a highly sought-after speaker on issues of health care, social responsibility, technology, education, STEM, and motivation.

Dr. Jemison is the Founder and President of The Jemison Group, Inc. (JG) – a technology consulting firm integrating critical socio-cultural issues into the design of engineering and science projects, as well as BioSentient Corporation - a medical devices and services company focused on improving health and human performance is such a company. An inductee of the National Women’s Hall of Fame and the International Space Hall of Fame, she is the author of Find Where the Wind Goes: Moments from My Life and editor of 100 Year Starship Canopus Award Anthology. Dr. Jemison is in demand with groups including DePaul University, MKTG, Girl Scouts of the USA, Qatar Foundation, among many others.

Susan Dentzer is one of the nation's most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries and analyses in print publications such as Modern Healthcare, NEJM Catalyst, and the Annals of Internal Medicine. She was also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care. She brings sharp analysis to the state of healthcare today, economic and budgetary issues, as well as the future of social security and Medicare.  

Susan Dentzer is Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University. Based in Washington, DC, where the center’s research team is located, she focuses on aspects of the COVID-19 pandemic response; health system transformation, such as through telehealth; biopharmaceutical policy; health coverage expansion, and other key health policy issues.

From 2016 to 2019, Dentzer was President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation, a nonprofit, nonpartisan organization then composed of more than 80 stakeholder organizations from across all key sectors of health and health care. From 2013 to 2016, she was senior policy adviser to the Robert Wood Johnson Foundation, the nation’s largest philanthropy focused on health and health care in the United States, and before that, was the editor-in-chief of the policy journal Health Affairs. From 1998 to 2008, she was the on-air Health Correspondent for the PBS NewsHour. Dentzer wrote and hosted the 2015 PBS documentary, Reinventing American Healthcare, focusing on the innovations pioneered by the Geisinger Health System and spread to health systems across the nation.

First and foremost, John is a thinker. A thinker entrenched in the world of science, medicine and innovation. John is the founder of NOSTALAB—a digital health think tank.   He’s currently ranked as the #1 global influencer in digital health and generally regarded as one of the top global strategic and creative thinkers in this important and expanding area. 

John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of innovation,” a process where strategy and creativity work together to create inflection points in the market. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to patients, clinicians and scientists. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future of health innovation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change in the health / tech marketplaces.

Leading researcher on aging and bestselling author, Professor Dr. David Sinclair is regarded as the world’s foremost expert on human longevity. A professor in the Genetics Department at Harvard Medical School, Dr. Sinclair heads a leading research lab that has discovered why we age and how to control it. He is the inventor on more than 50 patents, has published over 180 papers that have been cited 83,000 times, and is the author of the New York Times bestseller Lifespan: Why We Age and Why We Don't Have To, which The Wall Street Journal called “brilliant and enthralling.” Dr. Sinclair is a serial entrepreneur who has co-founded more than a dozen successful companies including MetroBiotech, EdenRoc Sciences, Tally Health, and Life Biosciences. An expert communicator of complex medical and scientific material, Dr. Sinclair is a highly sought-after speaker for his cutting edge innovations, insights about the influence of science on our lives and lifespans, and more.

Dr. Sinclair and his work have been featured on 60 Minutes, Today, The Wall Street Journal, The New York Times, Fortune, and Newsweek, among others, and has been named to TIME’s lists of the “100 Most Influential People in the World” as well as the “Top 50 People in Healthcare.” He has received more than 40 awards for his research and scientific breakthroughs, including Innovator of the Year, NIH’s Pioneer Award, and an appointment as an Officer of the Order of Australia – the equivalent of a knighthood – for his work in scientific communication and national security. His podcast Lifespan is one of the world’s most popular in the health and fitness category. Dr. Sinclair holds board seats on for-profit and non-profit organizations, co-founded the scientific journal Aging, as well as Fully Aligned LLC, which works to democratize access to knowledge and tools to enhance mind and body wellbeing.

More than an electrifying speaker, Jamie Metzl is a trusted and sought-after expert on the ever-evolving global geopolitical and biotechnology landscapes. Having spoken around the world and at major companies from Walmart to Google on the geopolitical outlook, how a rising China is transforming the world as we know it, and the latest advances in biotechnology, Metzl is praised as “a fantastic authority” (HSBC) and “an absolute tour de force” (Network 20/20), guaranteed to leave your audience engaged and more deeply informed.  A current Senior Fellow of the Atlantic Council, and an founding member of the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing, Metzl is frequently in-demand by major outlets such as CNN and Bloomberg for his sharp, dynamic analysis on the most pressing foreign policy issues and expertise on Asia’s economy and politics.

Having served in high level positions in the White House, State Department, and Senate, as well as run a major international affairs organization, Metzl draws from his cutting edge experience in both the public and private sector to provide transformative insights and actionable takeaways for every audience. Whether shedding light on what Asia’s economic growth means for the global geopolitical outlook and how businesses can best prepare, or diving into the future of the genetics revolution and the impacts that should be on company’s radars, Metzl’s researched-based, thought-provoking talks leave individuals and organizations equipped to keep up with changing times.

Claire L. Evans is a writer and musician. She is the singer and coauthor of the multiple Webby and GRAMMY-nominated pop group YACHT, known for their expansive investigations into the intersection of art and technology. Their groundbreaking 2019 release, Chain Tripping, was produced in collaboration with machine learning researchers and artists, and Claire has spoken about YACHT’s unique working process—and the significance of AI as a creative tool—at academic computer science conferences and music festivals alike.

Claire has her hands in past and future simultaneously: as the founding editor of VICE’s Terraform, she has published leading and emerging voices in speculative fiction, and as the author of Broad Band: The Untold Story of the Women who Made the Internet (Penguin Random House, 2018), she helps audiences understand the true history of technology. Broad Band has received acclaim from The New York Times, The Wall Street Journal, Kirkus, Booklist, Publisher’s Weekly, and Scientific American, and been featured on NPR’s Science Friday.

Claire writes extensively about computation, biology, and technology culture and history for outlets such as VICE, Rhizome, The Guardian, WIRED, Rest of World, the Los Angeles Review of Books, Document Journal, Eye on Design, Quartz, OneZero, PioneerWorks, and Aeon, among others. She lives in Los Angeles, where she is a faculty advisor to graduate design students at Art Center College of Design.

Using scatological research methods that might repel the squeamish, microbial researcher Rob Knight uncovers the secret ecosystem (or "microbiome") of microbes that inhabit our bodies -- and the bodies of every creature on earth. In the process, he’s discovered a complex internal ecology that affects everything from weight loss to our susceptibility to disease. As he said to Nature, "What motivates me, from a pragmatic standpoint, is how understanding the microbial world might help us improve human and environmental health.” 
 
Knight’s recent projects include the American Gut, an attempt to map the unique microbiome of the United States using open-access data mining tools and citizen-scientists to discover how lifestyle and diet affect our internal flora and fauna, and our overall health. He is also co-founder of the Earth Microbiome Project and the company Biota, Inc., which uses DNA from microbes in the subsurface to guide oilfield decisions. 

Dr. Fotuhi received his doctorate degree in neuroscience from Johns Hopkins University in 1992 and his Medical Degree from Harvard Medical School in 1997.

Through his 30 years of teaching, clinical work, and neuroscience research, Dr. Fotuhi has developed a multidisciplinary program for enhancing brain vitality and cognitive capacity at any age. His innovative and effective “Brain Fitness Program” includes a baseline “Brain Portfolio” assessment and 12 bi-weekly brain training sessions that address lifestyle factors and cognitive stimulation. He has published the successful results of this program for patients with memory loss with aging, concussion, and ADHD in several scientific journals and three books including the recently released Boost Your Brain, the New Art and Science Behind Enhanced Brain Performance.

Dr. Fotuhi is now one of the foremost authorities in the field of memory, concussion, and successful aging. He has given lectures at academic centers and large organizations in more than 20 countries around the world. He enjoys educating the public about the new discoveries in the field of neuroscience and has been interviewed by the main media networks in US.

Dr. Fotuhi serves as an adjunct professor at George Washington University and also teaches at Johns Hopkins University and Harvard Medical School.

Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 20 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft serves as Faculty Chair for Medicine for Singularity University, and is founding Executive Director of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. He is board certified in Internal Medicine & Pediatrics with specialty training in hematology/ oncology and bone marrow transplantation, and has multiple patents and publications in major biomedical journals. His various TEDTalks talks have over 1 million views. He is founder of RegenMed Systems & Bioniq Health and advises many biomedical startups including Scanadu, Jointly Health, and others including the X-Prize and Qualcomm Life.